US halt to plasma therapy brings a severe jolt to treatment plans in India

​​The study on plasma therapy by the ICMR is still ongoing, and the results will be shared on completion of the study. The ambiguity, experts say, is helping the private hospitals that are prescribing it claiming that it is a magic bullet.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/34jSuJ9
via IFTTT